Catalyst Wire Dossier Catalyst Wire Dossier

Transdermal SFG-02

SFG-02 · Juro Sciences Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transdermal SFG-02, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability and Pharmacokinetics of Transdermal SFG-02 in Healthy Participants [Phase 1]

See pricing